
|Articles|July 6, 2017
All Healthcare is not Local: The Human Cost of Disparate Health Data
Improving care coordination across the healthcare continuum has the potential to dramatically improve patient care, reduce duplicative tests and procedures, and positively impact care quality. This whitepaper explores data coordination that more easily locates records, reduces test and procedure duplication - and boosts your quality of care.
Advertisement
Improving care coordination across the healthcare continuum has the potential to dramatically improve patient care, reduce duplicative tests and procedures, and positively impact care quality. This whitepaper explores data coordination that more easily locates records, reduces test and procedure duplication - and boosts your quality of care.
Advertisement
Related to this article

Non-English-speaking families were far less likely to introduce peanut by 6 months (OR, 0.21) in a 3,170-child study presented at ACAAI 2026.

In an ACAAI 2026 survey, 85% of clinicians knew food allergy panels often yield false positives, yet many ordered them for unvalidated uses.

Full OptIMMize-1 results show high skin clearance rates with risankizumab in children and teens with psoriasis, sustained through 52 weeks.

Classroom engagement scores in digital gradebooks predicted substance use by eighth grade better than GPA (cross-validated AUC, 0.79 vs 0.63).

Children living more than 60 miles from their surgical hospital had higher complication odds and longer stays after common procedures.

Emily Becker, MD, discusses the role of AhR agonists, skin barrier function, and steroid-free treatment options for pediatric atopic dermatitis.

Post hoc data show cariprazine improved both manic and depressive symptoms through 52 weeks in youth aged 10 to 17 years with bipolar I disorder.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
How pediatricians can reframe vaccine conversations
2
FDA investigates malignancy risk with SMA gene therapy Zolgensma
3
Distance to surgery linked to complications, longer stays in children
4
Risankizumab shows 52-week efficacy in pediatric psoriasis trial
5

